The purpose of this task order is to (a) acquiring, procuring and/or manufacturing materials required for the generation of a scalable in vitro transcription (IVT) reaction, the purification of the…
Active Awarded Last action
- Contract number
- 75N93023F00001
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,769,527
Award facts
- Contract value 65% obligated
-
- $6,769,527.00 Current, with exercised options
- $10,383,334.00 Potential, with all options
- Completion date 89% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27708, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $595,226 | |
| Original award | $6,174,301 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Duke University on August 30, 2023, with a ceiling value of $10,383,334 under the Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents IDIQ. The order funds preclinical and translational vaccine development support, including in vitro transcription materials procurement, mRNA purification, lipid nanoparticle synthesis, and cGMP manufacture, fill-finish, release, analytical testing, and stability programs for mRNA-lipid nanoparticle-based HIV immunogens.
Place of performance is Durham, NC. The order is priced on a cost-no-fee basis with a completion date of March 28, 2027. Service Contract Inventory reporting shows Duke self-performed all work with 0.6 FTEs in the most recent fiscal year (FY2025), when $1.1 million was invoiced. In FY2024, the government paid $616.28 per hour across 231 contractor hours at 0.1 FTEs. No subcontractors were reported.
Description
The purpose of this task order is to (a) acquiring, procuring and/or manufacturing materials required for the generation of a scalable in vitro transcription (IVT) reaction, the purification of the transcribed mrna, procurement/synthesis of lipid raw
Quick answers
Who was awarded contract 75N93023F00001?
75N93023F00001 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 30, 2023.
How much is contract 75N93023F00001 worth?
The government has obligated $6,769,527 on 75N93023F00001. Its potential value, with all options, is $10,383,334.
Is contract 75N93023F00001 an order under another contract?
Yes. 75N93023F00001 is a delivery order under 75N93022D00003, an indefinite delivery contract, on Preclinical And Translational Vaccine Development For HIV And Other Candidate Agents.
Was contract 75N93023F00001 competed?
The extent of competition for 75N93023F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award